Peter Taylor

8.2k total citations · 2 hit papers
124 papers, 4.2k citations indexed

About

Peter Taylor is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Taylor has authored 124 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Pediatrics, Perinatology and Child Health and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Taylor's work include Thyroid Disorders and Treatments (69 papers), Thyroid Cancer Diagnosis and Treatment (36 papers) and Growth Hormone and Insulin-like Growth Factors (23 papers). Peter Taylor is often cited by papers focused on Thyroid Disorders and Treatments (69 papers), Thyroid Cancer Diagnosis and Treatment (36 papers) and Growth Hormone and Insulin-like Growth Factors (23 papers). Peter Taylor collaborates with scholars based in United Kingdom, United States and Australia. Peter Taylor's co-authors include Colin Dayan, Onyebuchi Okosieme, John H. Lazarus, A. Scholz, Gala Gutiérrez-Buey, Diana Albrecht, Salman Razvi, John Davies, Simon H. S. Pearce and Mohd Shazli Draman and has published in prestigious journals such as The Lancet, Angewandte Chemie International Edition and Journal of the American College of Cardiology.

In The Last Decade

Peter Taylor

117 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global epidemiology of hyperthyroidism and hypothyroidism

2018 884 citations Peter Taylor, Colin Dayan et al. profile →
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK

2023 381 citations Nathalie Conrad, Shivani Misra et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Taylor United Kingdom	28	2.5k	705	600	484	420	124	4.2k
Layal Chaker Netherlands	33	2.5k 1.0×	315 0.4×	435 0.7×	538 1.1×	496 1.2×	93	4.2k
Francesco Trimarchi Italy	40	3.8k 1.5×	543 0.8×	891 1.5×	677 1.4×	499 1.2×	227	5.5k
Nils Knudsen Denmark	41	4.0k 1.6×	693 1.0×	285 0.5×	554 1.1×	259 0.6×	75	4.7k
Salman Razvi United Kingdom	29	3.2k 1.3×	558 0.8×	568 0.9×	226 0.5×	238 0.6×	94	4.2k
Bijay Vaidya United Kingdom	39	3.6k 1.4×	699 1.0×	398 0.7×	632 1.3×	508 1.2×	127	5.3k
Onyebuchi Okosieme United Kingdom	25	2.4k 1.0×	340 0.5×	322 0.5×	368 0.8×	266 0.6×	103	3.1k
Mark Vanderpump United Kingdom	25	4.3k 1.7×	631 0.9×	502 0.8×	371 0.8×	405 1.0×	57	5.4k
Inge Bülow Pedersen Denmark	38	3.2k 1.3×	740 1.0×	210 0.3×	548 1.1×	195 0.5×	73	3.8k
Trine Bjøro Norway	41	3.0k 1.2×	425 0.6×	696 1.2×	491 1.0×	379 0.9×	119	5.1k
Marco Medici Netherlands	36	2.8k 1.1×	315 0.4×	375 0.6×	913 1.9×	215 0.5×	88	3.8k

Countries citing papers authored by Peter Taylor

Since Specialization

Citations

This map shows the geographic impact of Peter Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Taylor more than expected).

Fields of papers citing papers by Peter Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Taylor. The network helps show where Peter Taylor may publish in the future.

Co-authorship network of co-authors of Peter Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Taylor. A scholar is included among the top collaborators of Peter Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Taylor. Peter Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor, Peter, Lakdasa Premawardhana, Mike Stedman, et al.. (2025). Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 110(11). 3278–3288. 1 indexed citations

Premawardhana, Lakdasa, et al.. (2025). Evaluating the Link Between Thyroid Function Test Results and Levothyroxine Dose in the Management of Hypothyroidism: Can We Improve Dosing Regimes?. Clinical Endocrinology. 104(4). 372–385.

Premawardhana, Lakdasa, et al.. (2024). Liothyronine (LT3) prescribing in England: Are cost constraints inhibiting guideline implementation?. Clinical Endocrinology. 101(1). 62–68. 2 indexed citations

Premawardhana, Lakdasa, et al.. (2023). Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design. Frontiers in Endocrinology. 14. 1282608–1282608. 4 indexed citations

Conrad, Nathalie, Shivani Misra, Jan Y. Verbakel, et al.. (2023). OP0007 INCIDENCE, PREVALENCE AND CO-OCCURRENCE OF AUTOIMMUNE DISORDERS, TRENDS OVER TIME AND BY AGE, SEX AND SOCIOECONOMIC STATUS. A POPULATION-BASED STUDY IN 22 MILLION INDIVIDUALS.. Annals of the Rheumatic Diseases. 82. 5–6. 3 indexed citations

Biscarini, Filippo, Giulia Masetti, Ilaria Muller, et al.. (2023). Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study. The Journal of Clinical Endocrinology & Metabolism. 108(8). 2065–2077. 37 indexed citations

Mulder, Tessa A., Purdey J. Campbell, Peter Taylor, et al.. (2023). Genetic determinants of thyroid function in children. European Journal of Endocrinology. 189(2). 164–174.

Minassian, Caroline, et al.. (2023). Preconception Management of Hyperthyroidism and Thyroid Status in Subsequent Pregnancy: A Population-Based Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 108(11). 2886–2897. 4 indexed citations

Taylor, Peter, Stephanie Hanna, Victoria Wilson, et al.. (2023). Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial. The Journal of Clinical Endocrinology & Metabolism. 108(10). 2615–2625. 5 indexed citations

10.

Panagiotou, Grigorios, Peter Taylor, Aled Rees, & Onyebuchi Okosieme. (2022). Late offspring effects of antenatal thyroid screening. British Medical Bulletin. 143(1). 16–29. 5 indexed citations

11.

Taylor, Peter, et al.. (2022). Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data. Diabetic Medicine. 39(9). e14908–e14908. 1 indexed citations

12.

Draman, Mohd Shazli, Peter Taylor, Ilaria Muller, et al.. (2021). Expression of Endogenous Putative TSH Binding Protein in Orbit. Current Issues in Molecular Biology. 43(3). 1794–1804. 5 indexed citations

13.

Lewis, S.A.E., et al.. (2021). Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta‐analysis. Clinical Endocrinology. 96(6). 857–868. 12 indexed citations

14.

Stedman, Mike, Peter Taylor, Lakdasa Premawardhana, et al.. (2021). Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011–2020. Clinical Endocrinology. 94(6). 980–989. 12 indexed citations

15.

Roberts, Matthew M., et al.. (2018). Diffuse low grade glioma after the 2016 WHO update, seizure characteristics, imaging correlates and outcomes. Clinical Neurology and Neurosurgery. 175. 9–15. 14 indexed citations

16.

Taylor, Peter & John Davies. (2018). A review of the growing risk of vitamin D toxicity from inappropriate practice. British Journal of Clinical Pharmacology. 84(6). 1121–1127. 120 indexed citations

17.

Okosieme, Onyebuchi, et al.. (2018). Preconception management of thyroid dysfunction. Clinical Endocrinology. 89(3). 269–279. 39 indexed citations

18.

Taylor, Peter, Paul White, Victoria Wilson, et al.. (2018). Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial. Psychology Health & Medicine. 23(sup1). 1–15. 10 indexed citations

19.

Taylor, Peter, et al.. (2016). Thyroid antibody-negative euthyroid Graves’ ophthalmopathy. Endocrinology Diabetes and Metabolism Case Reports. 2016. 160008–160008. 26 indexed citations

20.

Taylor, Peter, et al.. (1995). Systemic acquired resistance in cucumber leaves is correlated with resistance of the leaves to maceration by cell wall-degrading enzymes.. Aspects of applied biology. 349–353. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact